Clinical Trials Browser

Opsoclonus-Myoclonus Syndrome × Clear all

NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Phase 2 Active not recruiting

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

NCT01868269 2025-02-03

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

Phase 3 Completed

Neuroblastoma, Opsoclonus-Myoclonus Syndrome

NCT00202930 2021-01-22

Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma

Phase 2 Terminated

4 enrolled 6 charts

Neuroblastoma, Opsoclonus-Myoclonus Syndrome

NCT00806182 2017-05-23

OMS

Ataxia, Autoimmune Diseases, Neuroblastoma, Opsoclonus-Myoclonus Syndrome

NCT00244361 2011-05-10

Effectiveness of Rituximab in Pediatric OMS Patients.

Phase 1/2 Completed

Ataxia, Myoclonus, Ocular Motility Disorders, Opsoclonus-Myoclonus Syndrome